BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8228569)

  • 1. Altered eicosanoid levels in human colon cancer.
    Rigas B; Goldman IS; Levine L
    J Lab Clin Med; 1993 Nov; 122(5):518-23. PubMed ID: 8228569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
    Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
    Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
    Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eicosanoids as mediators in ARDS].
    Loick HM; Theissen JL
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Feb; 29(1):3-9. PubMed ID: 8142566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa.
    Treiber G; Wex T; Link A; Vieth M; Laufer S; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Jan; 23(1):155-67. PubMed ID: 16393293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
    Mahipal A; Anderson KE; Limburg PJ; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-HETE is the main eicosanoid formed by human colonic mucosa.
    Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
    Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.
    Freedman RS; Wang E; Voiculescu S; Patenia R; Bassett RL; Deavers M; Marincola FM; Yang P; Newman RA
    Clin Cancer Res; 2007 Oct; 13(19):5736-44. PubMed ID: 17908963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system.
    Müller B
    Therapie; 1991; 46(3):217-21. PubMed ID: 1792655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of non-steroidal anti-inflammatory drugs on the in vivo synthesis of thromboxane and prostacyclin in humans.
    Drvota V; Vesterqvist O; Gréen K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():153-6. PubMed ID: 1825533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.
    Krishnan K; Ruffin MT; Normolle D; Shureiqi I; Burney K; Bailey J; Peters-Golden M; Rock CL; Boland CR; Brenner DE
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):447-53. PubMed ID: 11352853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS; Rao CV
    J Environ Pathol Toxicol Oncol; 2002; 21(2):155-64. PubMed ID: 12086402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.
    Montuschi P; Macagno F; Parente P; Valente S; Lauriola L; Ciappi G; Kharitonov SA; Barnes PJ; Ciabattoni G
    Thorax; 2005 Oct; 60(10):827-33. PubMed ID: 16192367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis of eicosanoids in the colonic mucosa in patients with ulcerative colitis].
    Pavlenko VV; Iagoda AV
    Klin Med (Mosk); 2003; 81(10):39-43. PubMed ID: 14664173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.